Maastricht University Medical Center+ or Maastricht UMC+ is an academic hospital in the city of Maastricht and affiliated with Maastricht University. Maastricht UMC+ is one of the eight university medical centers in the Netherlands and is part of Netherlands Federation of University Medical Centres

There are 715 beds in Maastricht University Medical Center.

During the past decade, Maastricht University Medical Center conducted 625 clinical trials. In the 10-year time frame, 625 clinical trials started and 107 clinical trials were completed, i.e. on average, 17.1% percent of trials that started reached the finish line to date. In the past 5 years, 240 clinical trials started and 72 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maastricht University Medical Center" #1 sponsor was "Maastricht University Medical Center" with 459 trials, followed by "Radboud University Medical Center" with 31 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 28 trials sponsored, "The Netherlands Cancer Institute" with 15 trials sponsored and "University Medical Center Groningen" with 15 trials sponsored. Other sponsors include 457 different institutions and companies that sponsored additional 253 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maastricht University Medical Center" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 63 trials as a collaborator, "Maastricht University Medical Center" with 45 trials as a collaborator, "Radboud University Medical Center" with 22 trials as a collaborator, "Dutch Cancer Society" with 21 trials as a collaborator and "Erasmus Medical Center" with 21 trials as a collaborator. Other collaborators include 973 different institutions and companies that were collaborators in the rest 595 trials.

According to Clinical.Site data, the most researched conditions in "Maastricht University Medical Center" are "Heart Failure" (30 trials), "Breast Cancer" (27 trials), "Obesity" (27 trials), "Atrial Fibrillation" (25 trials) and "Coronary Artery Disease" (15 trials). Many other conditions were trialed in "Maastricht University Medical Center" in a lesser frequency.

Most popular intervention types in "Maastricht University Medical Center" are "Drug" (365 trials), "Device" (174 trials), "Other" (166 trials), "Procedure" (129 trials) and "Dietary Supplement" (94 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (102 trials), "cisplatin" (11 trials), "placebo" (11 trials), "radiation therapy" (10 trials) and "Bevacizumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Maastricht University Medical Center" are 855 trials for "All" genders, 99 trials for "Female" genders and 56 trials for "Male" genders.

Currently, there are 286 active trials in "Maastricht University Medical Center". 13 are not yet recruiting, 182 are recruiting, 83 are Active, not recruiting, and 8 are Enrolling by invitation. In total, there were 499 completed trials in Maastricht University Medical Center, 4 suspended trials, and 82 terminated clinical trials to date.

Out of the total trials that were conducted in Maastricht University Medical Center, 33 "Phase 1" clinical trials were conducted, 129 "Phase 2" clinical trials and 206 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 61 trials, and there were also 364 trials that are defined as “Not Applicable".

Maastricht University Medical Center has several departments that took part in Clinical trials: "University Eye Clinic Maastricht" - 6 trials, "Maastricht University Medical Centre; Dermatologie" - 2 trials, "Maastricht University Medical Centre; Rheumatology" - 2 trials